1.Curtis, KA et al. (2013) Evaluation of a multiplex assay for estimation of HIV-1 incidence. PLoS ONE 8(5), e64201.
2.Park, SY et al. (2014) Developing high-throughput HIV incidence assay with pyrosequencing platform. Journal of Virology 88(5), 2977–2990.
3.WHO U. (2011) When and how to use assays for recent infection to estimate HIV incidence at a population level. In Press, W (ed.), WHO Library Cataloguing-in-Publication Data. Switzerland, pp. 1–49.
4.Busch, MP et al. (2010) Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. Aids (london, England) 24(18), 2763–2771.
5.Moyo, S et al. (2015) Identifying recent HIV infections: from serological assays to genomics. Viruses 7(10), 5508–5524.
6.Duong, YT et al. (2012) Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies. PLoS ONE 7(3), e33328.
7.Parekh, BS et al. (2002) Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Research and Human Retroviruses 18(4), 295–307.
8.Keating, SM et al. (2012) Lower-sensitivity and avidity modifications of the vitros anti-HIV 1 + 2 assay for detection of recent HIV infections and incidence estimation. Journal of Clinical Microbiology 50(12), 3968–3976.
9.Kassanjee, R et al. (2014) Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. Aids (London, England) 28(16), 2439–2449.
10.Incidence Assay Critical Path Working G (2011) More and better information to tackle HIV epidemics: towards improved HIV incidence assays. PLoS Medicine 8(6), e1001045.
11.Yates, NL et al. (2011) Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection. Aids (london, England) 25(17), 2089–2097.
12.Stapleton, NM et al. (2011) Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nature Communications 2, 599.
13.Khalife, J et al. (1988) Isotypic restriction of the antibody response to human immunodeficiency virus. AIDS Research and Human Retroviruses 4(1), 3–9.
14.Binley, JM et al. (1997) Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. Journal of Virology 71(4), 2799–2809.
15.Altschul, SF et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research 25(17), 3389–3402.
16.Altschul, SF et al. (2005) Protein database searches using compositionally adjusted substitution matrices. FEBS Journal 272(20), 5101–5109.
17.Crestani, S et al. (2016) Enhanced target-specific signal detection using an Escherichia coli lysate in multiplex microbead immunoassays with E. coli-derived recombinant antigens. Journal of Immunological Methods 435, 17–26.
18.Hanley, JA and McNeil, BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143(1), 29–36.
19.Zweig, MH and Campbell, G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clinical Chemistry 39(4), 561–577.
20.DeSilva, B et al. (2003) Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharmaceutical Research 20(11), 1885–1900.
21.Tomaras, GD and Haynes, BF (2009) HIV-1-specific antibody responses during acute and chronic HIV-1 infection. Current Opinion in HIV and AIDS 4(5), 373–379.
22.Wilson, KM et al. (2004) Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations. Aids (London, England) 18(17), 2253–2259.
23.Ferrante, A, Beard, LJ and Feldman, RG (1990) Igg subclass distribution of antibodies to bacterial and viral antigens. Pediatric Infectious Disease Journal 9(Suppl. 8), S16–S24.
24.Banerjee, K et al. (2010) Igg subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines. AIDS Research and Human Retroviruses 26(4), 445–458.
25.McDougal, JS et al. (1987) Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progression. Journal of Clinical Investigation 80(2), 316–324.
27.Vidarsson, G, Dekkers, G and Rispens, T (2014) Igg subclasses and allotypes: from structure to effector functions. Frontiers in Immunology 5, 520.
28.Snapper, CM and Mond, JJ (1993) Towards a comprehensive view of immunoglobulin class switching. Immunology Today 14(1), 15–17.
29.Germann, T et al. (1995) Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. European Journal of Immunology 25(3), 823–829.